Head-to-head · WeighScore
Remi Meds vs Tonik Wellness
By GLP-1 ScorecardUpdated
Score comparison
Tonik Wellness has the higher recorded score — 69/100 to 48.4/100.
Tonik Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Tonik lists monthly, quarterly and annual GLP-1 plans. Its medication subscription policy sets a three-month minimum.
Before you choose
Before comparing the headline prices, the Remi Meds review and the Tonik Wellness review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Remi Meds vs WeightRx and Renlo Health vs Tonik Wellness compare each of them with another graded program, and the list of alternatives to Remi Meds ranks the programs closest to Remi Meds on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the MEDGm review covers one graded close to these two, at 59.1/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Remi Meds | Tonik Wellness |
|---|---|---|
| WeighScore | 48.4/100 | 69/100 |
| Grade | C | C |
| Site position | #511 | #150 |
| Semaglutide | $249/mo (0.25 mg dose, compounded) | $225/mo (advertised monthly plan, minimum commitment applies) |
| Tirzepatide | $349/mo (2.25 mg dose, compounded) | $349/mo (advertised monthly plan, minimum commitment applies) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Names its compounding pharmacy (Strive Pharmacy, Gilbert AZ) — stronger transparency than peers
- LegitScript verification badge on the homepage
- Publishes 503A FDCA compliance language on the tirzepatide page
- Per-dose-tier pricing fully shown — no 'as low as' floor-only obfuscation
- Operating corporate entity disclosed (T-C Health Co)
What to consider
- No named medical director, founder, or physician on any public page
- States served not listed — 'nationwide' claim with no per-state detail
- Clinical care runs through Beluga Health, a network a 2026 StatNews analysis tied to many FDA-warned GLP-1 companies (Remi Meds itself not FDA-warned)
- Year founded and corporate history are opaque
- Two phone numbers and a secondary 'Rekindle RX' email hint at shared infrastructure
Strengths
- Shows quarterly and annual billing amounts for both advertised medications.
- Describes lab review with a provider.
- Names Strive and Olympia as partner pharmacies.
What to consider
- Monthly access language needs reconciling with the three-month subscription minimum.
- The plan cards leave lab charges and the selected dispensing location unconfirmed.
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.